Lorien Moore

Lorien Moore has extensive work experience in the biopharmaceutical industry. Lorien began their career in 1995 at Ford Motor Company, where they held various roles in Marketing, Sales and Finance. In 2003, they moved to Gillette/P&G, where they held the roles of Product Manager for Gillette Razors and Manager of Forecasting and Analysis. In 2007, they joined Cubist Pharmaceuticals as Senior Director of International Alliance & Project Management, Director of New Product Planning, and Senior Manager of Head of Market Research and Forecasting. In 2015, they founded Malin Rock LLC, a biopharmaceutical consulting firm. In 2016, they became Senior Director of Alliance Management, Business Development and Strategy at Seres Therapeutics. In 2017, they moved to Flexion Therapeutics as Senior Director of Commercial Strategy and Market Development. In 2019, they joined X-Biotix Therapeutics, Inc. as Head of Portfolio Management and Business Operations. In 2020, they became Executive Director of Corporate Development at Constellation Pharmaceuticals. In 2021, they joined Yumanity Therapeutics as VP, Head Program Management and New Product Planning. Most recently, in 2022 they became VP of Corporate Development and Business Operations at Vesigen Therapeutics, Inc.

Lorien Moore completed their MBA at the MIT Sloan School of Management from 1998 to 2000. Lorien then participated in the International MBA Exchange Program at IESE Business School in Barcelona in 2000. Prior to that, they received their BA in Finance, with distinction, from the University of Illinois Urbana-Champaign from 1991 to 1995.